Surprising finding provides more support for Alzheimer’s being an autoimmune disease

March 10, 2015 - Brain levels of the lipid ceramide are high in Alzheimer’s disease, and now scientists have found increased levels of an antibody to the lipid in their disease model. More...

Follow IOS Press on Facebook

March 3, 2015 - We are pleased to inform you that IOS Press now has its own Facebook page: www.facebook.com/publisheriospress. More...

Levodopa-Carbidopa Intestinal Gel May Prove More Effective for Long-Term Treatment of Parkinson’s Disease than Standard Levodopa

Report in the Journal of Parkinson’s Disease presents data from one-year trial on long-term safety, efficacy, and quality of life in advanced PD patients using levodopa-carbidopa intestinal gel

February 27, 2015 - Although levodopa remains the “gold standard” to effectively control motor deficits in the treatment of early stage Parkinson’s disease (PD), it loses effectiveness as the disease progresses. After four to six years of treatment with oral medications for Parkinson’s disease, about 40% of patients experience lack of muscle control (dyskinesias), end-of-dose wearing off, and fluctuations in “On/Off” states. By nine years of treatment, about 90% will suffer these effects. More...

Cardiac and Respiratory Function Supported by Abdominal Muscles in Muscular Dystrophy

Mouse Studies Show How Different Muscles Affected as Muscular Dystrophy Progresses, According to Report in the Journal of Neuromuscular Diseases

February 27, 2015 - The muscular dystrophies are known to target various muscle groups differentially. In addition to making limb muscles weak, muscular dystrophy (MD) can also lead to decreased function of specific muscles involved in respiration causing breathing difficulties as well as leading to cardiac problems. More...